Neuroradiologic evidence of pre-synaptic and post-synaptic nigrostriatal dopaminergic dysfunction in idiopathic basal ganglia calcification: A case report

Journal of Neuroimaging

Volumn 20, Issue 2, 2010, Pages 189-191

  Saito, Takahiro ^a   Nakamura, Mitsuru ^a   Shimizu, Teruhiko ^a   Oda, Keiichi ^b   Ishiwata, Kiichi ^a   Ishii, Kenji ^b   Isse, Kunihiro ^b  

^a Toshima Tokyo Metropolitan Hospital   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Catatonia; CFT; Idiopathic basal ganglia calcification; PET; RAC

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER C 11; CARBON 11; FLUORODEOXYGLUCOSE F 18; LITHIUM CARBONATE; RACLOPRIDE C 11; RISPERIDONE; TRAZODONE; UNCLASSIFIED DRUG; 6 FLUORODOPA F 18; DOPA; DOPAMINE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGITATION; ARTICLE; BRAIN CALCIFICATION; CASE REPORT; CAUDATE NUCLEUS; DENTATE NUCLEUS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOLALIA; ELECTROCONVULSIVE THERAPY; EXTRAPYRAMIDAL SYMPTOM; EXTRAPYRAMIDAL SYNDROME; FEMALE; FRONTAL CORTEX; GLOBUS PALLIDUS; GLUCOSE METABOLISM; HUMAN; IDIOPATHIC BASAL GANGLIA CALCIFICATION; MOOD DISORDER; NEUROIMAGING; NIGRONEOSTRIATAL SYSTEM; PARIETAL LOBE; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PSYCHOSIS; PULVINAR; PUTAMEN; SUICIDAL IDEATION; SUICIDE ATTEMPT; TEMPORAL CORTEX; ANALOGS AND DERIVATIVES; CORPUS STRIATUM; DIAGNOSTIC USE; METABOLISM; SCINTISCANNING;

ADULT; BASAL GANGLIA DISEASES; CORPUS STRIATUM; DIHYDROXYPHENYLALANINE; DOPAMINE; FEMALE; HUMANS; RADIOPHARMACEUTICALS;

EID: 77950622322     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2008.00314.x     Document Type: Article

References (15)

1. Förstl H, Krumm B, Eden S, et al. What is the psychiatric significance of bilateral basal ganglia mineralization? Biol Psychiatry 1991 29 : 827 833.
2. López-Villegas D, Kulisevsky J, Deus J, et al. Neuropsychological alterations in patients with computed tomography-detected basal ganglia calcification. Arch Neurol 1996 53 : 251 256.
3. Cummings JL, Gosenfeld LF, Houlihan JP, et al. Neuropsychiatric disturbances associated with idiopathic calcification of the basal ganglia. Biol Psychiatry 1983 18 : 591 601.
4. 18FDG-PET studies in a family with idiopathic basal ganglia calcification. J Neurol Sci 2007 258 : 115 122.
5. Savoldi F, Nappi G, Martignoni E, et al. Biochemical evidence of dopaminergic involvement in Fahr's syndrome. Acta Neurol 1980 2 : 231 239.
6. Manyam BV, Bhatt MH, Moore WD, et al. Bilateral striopallidodentate calcinosis: cerebrospinal fluid, imaging, and electrophysiological studies. Ann Neurol 1992 31 : 379 384.
7. Hashimoto M, Kawasaki K, Suzuki M, et al. Presynaptic and postsynaptic nigrostriatal dopaminergic functions in multiple system atrophy. Neuroreport 2008 19 : 145 150.
8. Suzuki Y, Mizoguchi M, Kiyosawa M, et al. Glucose hypermetabolism in the thalamus of patients with essential blepharospasm. J Neurol 2007 254 : 890 896.
9. 2 receptor occupancy in living human brain from plasma pharmacokinetics of antipsychotics. Int J Neuropsychopharmacol 2004 7 : 19 26.
10. Balsara JJ, Jadhav SA, Gaonkar RK, et al. Effect of the antidepressant trazodone, a 5-HT 2A/2C receptor antagonist, on the dopamine-dependent behaviors in rats. Psychopharmacology 2005 179 : 597 605.
11. Hempel A, Henze M, Berghoff C, et al. PET findings and neuropsychological deficits in a case of Fahr's disease. Psychiatry Res 2001 108 : 133 140.
12. Shouyama M, Kitabata Y, Kaku T, et al. Evaluation of regional cerebral blood flow in Fahr disease with schizophrenia-like psychosis. Am J Neuroradiol 2005 26 : 2527 2529.
13. Casanova MF, Araque JM. Mineralization of the basal ganglia: implications for neuropsychiatry, pathology and neuroimaging. Psychiatry Res 2003 121 : 59 87.
14. Northoff G. Neuroimaging and neurophysiology. In : Caroff SN, Mann SC, Francis A, Fricchione GL, eds. Catatonia. From Psychopathology to Neurobiology.
15. Shinotoh H. Neuroimaging of PD, PSP, CBD and MSA - PET and SPECT studies. J Neurol 2006 253 : 30 34.